Metabiomics Management Team

Thomas J. Kuehn, Ph.D.

Chairman and CEO

Dr. Kuehn is a visionary entrepreneur and inventor with 30-year career devoted to multidisciplinary science, R&D, and systems engineering management including experience in manufacturing, marketing, sales and service of advanced analytical instrumentation, biotechnology, bioinformatics, and information technology enterprises He co-founded and led several high-tech companies since 1982 including Viking Instruments, Ion Metrics, Biospherex, and Metabiomics. As co-founder of Viking Instruments he co-invented, designed, and manufactured portable GC/MS analytical instrumentation and later co-invented a portable IMS/MS at Ion Metrics. He has served as a Board member and investor in several start-up firms and consultant to Fortune 100 defense and information technology companies in R&D, systems integration, and business development roles.

Gregory J. Kuehn, MBA

President and COO

Gregory J. Kuehn, MBA, President and COO, is a co-founder with an MBA from the University of Colorado with BS from the College of William and Mary in molecular biology and computer science. He was a business consultant (2006-2010) at Flashback Technologies and VetDC in Colorado, with experience in marketing, sales, advertising, financial modeling, business plan and grant proposal writing, project management, knowledge management and web/graphic design. Founder of the CU Biotech Club. NCAA SN and AP Football All-American at W&M.

Christopher F. Metz

VP Business Development and Sales

 Christopher F. Metz is an experienced healthcare executive specializing in sales, business development, and long-term payer relationships. An acknowledged lab industry innovator with more than 25 years of results-driven leadership experience in the Anatomic Pathology/Clinical Lab industry, Mr. Metz gained his reputation by impacting organizational performance through the execution of multimillion-dollar business development, short/long term strategic planning, account management, contract negotiations and demonstrated success in the growth of laboratory businesses over time.

A graduate of Cornell University and a Captain in the Marine Corps, Mr. Metz was a co-founder of CBLPath, Inc., an independent AP lab he helped grow from $4MM to $85MM in five years before the sale of the company to Sonic Healthcare in 2010. During his 14-year tenure at DIANON Systems, Inc., prior to its sale to LabCorp in 2002, he initiated and executed unique risk-based contracts with commercial payers. Most recently, he spearheaded the recapitalization of Atlantic Diagnostic Laboratories and helped increase its profits 25% in its first year.

In addition, Mr. Metz sits on the board of Baker Industries, a Philadelphia-based nonprofit work rehabilitation program for adults on parole, in recovery, homeless, or who have been diagnosed with a disability. 

Louis Y. Korman, MD

Chief Medical Officer

Dr. Korman completed his medical school education at the State University of New York in Syracuse, graduating Cum Laude and being elected to the Alpha Omega Alpha Medical Honor Society. He moved to Washington, DC in 1978 to continue his training in Gastrointestinal Diseases at the National Institutes of Health Digestive Disease branch with an interest in the regulation of gastrointestinal function. Dr. Korman is a leading practitioner and expert in the diagnosis and treatment of patients with diseases of the gastrointestinal tract and liver and has extensive experience in basic and applied clinical research and the application of information technology to clinical practice. Dr. Korman is an attending physician in Chevy Chase Clinical Research and Capital Digestive Care, one of largest single specialty GI practice groups in the US with over fifty-five gastroenterologists. In addition to his clinical practice, he teaches gastroenterology and endoscopy in the Gastroenterology Training Program at the Veterans Administration Hospital/Georgetown University Fellowship program. Dr. Korman is a principal investigator for both NIH and industry sponsored clinical trials in gastrointestinal diseases.

Patrick M. Gillevet, Ph.D.

Life Science Advisory Board Chairman

Dr. Patrick Gillevet, Chairman of the life science advisory board, is a pioneering molecular ecologist, co-founder, and primary inventor of Metabiomics patented MultiTag™ Sequencing and other gateway technology. He brings extensive experience in development of technology and methodology in the fields of genomics and bioinformatics. He was the technical director of the Center of Prokaryotic Genome Analysis at the University of Illinois, the Director of the Harvard University Genome Laboratory from 1990-­1993, and currently heads the Microbiome Analysis Center at George Mason University in Manassas, VA.

Contact Us

3 + 8 =